Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2023-06-20
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main aim is to determine the accuracy and utility of the OxVPS compared to the current gold standard assessment in stroke survivors. In other words, how well can the Oxford Visual Perception Screening tool (OxVPS) identify stroke patients with visual perception problems?
Participants will completed the OxVPS and the current gold standards visual perception screening tool.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Oslo Study of Visual Impairment After Stroke (StrokeVIS)
NCT05809973
The Stroke Vision App: A Screening Tool for Visual Stroke
NCT02539381
Visual and Functional Assessment in Low Vision Patients
NCT01876147
A Study to Evaluate the BrainPort® Vision Device in Subjects Who Are Blind
NCT01488786
Performance of Long-wavelength Autofluorescence Imaging
NCT03592017
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will be recruited at stroke rehabilitation units at hospitals in the North East of England and in Oxfordshire.
Following consent:
* Participants will complete the paper version of the Oxford Visual Perception Screen OxVPS (\~15 min).
* Participants will complete screening for visual perception problems with a validated screening tool (\~30-120 min).
* Participants will complete screening for cognition alterations and sensory vision with validated screening tools. (\~30 min)
* Stroke details (time since stroke, severity) and demographic data (age, socio-economic status) will be collected to evaluated representativeness of the sample.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stroke survivors
Individuals who have survived a stroke
OxVPS
Comparing a new screening tool, the Oxford visual perception screening, to the gold standard, Rivermead Perceptual Battery Assessment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OxVPS
Comparing a new screening tool, the Oxford visual perception screening, to the gold standard, Rivermead Perceptual Battery Assessment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Within 6 weeks of confirmed stroke.
Exclusion Criteria
* Clinical concerns that patient is unable follow simple instructions.
* Clinical concerns that patient is unable to concentrate for 15 minutes.
* No capacity to provide informed consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute for Health Research, United Kingdom
OTHER_GOV
County Durham and Darlington NHS Foundation Trust
OTHER_GOV
University of Oxford
OTHER
Durham University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kate Cowen
Postdoc researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kathleen Vancleef, PhD
Role: PRINCIPAL_INVESTIGATOR
Durham University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Abingdon Community Hospital
Abingdon, , United Kingdom
Bishop Auckland Hospital
Bishop Auckland, , United Kingdom
Queen Elizabeth Hospital
Gateshead, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Durham University
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.